NEW YORK (GenomeWeb) – Thermo Fisher Scientific this week declared a quarterly cash dividend of $.15 per share, payable on Oct. 16 to shareholders of record as of Sept. 15.


Helix announced this week that its DNA sequencing laboratory has been accredited by the College of American Pathologists. Helix received CLIA accreditation in 2015. The company operates a next-generation sequencing laboratory in San Diego where it offers a proprietary sequencing assay called Exome+.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.